Tumor ‘Flare’ Hypercalcemia – An Additional Indication for Bisphosphonates?

Publisher： Karger

E-ISSN： 1423-0232|60|2|123-126

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.2, 2001-02, pp. : 123-126

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypercalcemia Associated with a Malignant Brenner Tumor Arising from a Mature Cystic Teratoma

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-11 ,pp. : 592-600

Karger

Access to resources Recommend Favorite

Growing indication for FNA to study and analyze tumor heterogeneity at metastatic sites

By  

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 7, 2014-07 ,pp. : 504-511

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 30-38

Karger

Access to resources Recommend Favorite

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1078-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite

Richter’s Syndrome with Hypercalcemia Induced by Tumor-Associated Production of Parathyroid Hormone-Related Peptide

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-01 ,pp. : 123-126

Karger

Access to resources Recommend Favorite